combretastatin has been researched along with warfarin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lipeeva, AV; Pokrovsky, AG; Pokrovsky, MA; Shakirov, MM; Shults, EE | 1 |
| Chaplin, DJ; Chen, Z; Devkota, L; Guddneppanavar, R; Hamel, E; Jelinek, CJ; Lin, CM; Liu, L; Lopez, R; Mason, RP; Pinney, KG; Strecker, TE; Tidmore, JK; Trawick, ML; Wang, Y | 1 |
2 other study(ies) available for combretastatin and warfarin
| Article | Year |
|---|---|
Synthesis and cytotoxic activity of a new group of heterocyclic analogues of the combretastatins.
Topics: Antineoplastic Agents, Phytogenic; Bibenzyls; Cell Line, Tumor; Coumarins; Drug Screening Assays, Antitumor; Ficusin; Furocoumarins; Humans; Molecular Structure; Neoplasms; Stilbenes; Structure-Activity Relationship; Tubulin Modulators | 2014 |
Design, synthesis, and biological evaluation of water-soluble amino acid prodrug conjugates derived from combretastatin, dihydronaphthalene, and benzosuberene-based parent vascular disrupting agents.
Topics: Amino Acids; Animals; Antineoplastic Agents; Bibenzyls; Breast; Breast Neoplasms; Cell Line, Tumor; Coumarins; Drug Design; Female; Humans; Mice; Mice, SCID; Naphthalenes; Neoplasms; Optical Imaging; Prodrugs; Solubility; Structure-Activity Relationship; Tubulin; Water | 2016 |